Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Hyperuricemia: early-phase trial registry
2 of 12 indexed Hyperuricemia trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,429 of 28,707 conditions by registered trial count.
12 US clinical trials · 2 currently recruiting · #1,429 of 28,707 conditions by registered trial count
Hyperuricemia: 12 US clinical trials tracked, 2 recruiting.
Hyperuricemia is the subject of 12 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most active sponsor is Arthrosi Therapeutics, running 3 of these trials.
Enrollment posture brief
Registry condition hyperuricemia
OPEN 2 | RECR 17% | LATE 3 | EARLY 8 | RANK #1429 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Acute Renal Failure (17% recruiting · 6 trials)
Hyperuricemia lists 2 open slots (17% of 12 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Hyperuricemia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Hyperuricemia is recruiting below its size-band peers.
2 of 12 indexed trials (16.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Hyperuricemia research.
Arthrosi Therapeutics accounts for 3 of 12 trials (25%). 9 distinct sponsors appear on at least one study for this condition label.
-
Most Hyperuricemia trials plan to enrol fewer than 100 people.
Median target enrolment is 32 among the 12 trials that report a genuine target (sentinel values excluded). 10 of those (83.3%) plan for fewer than 100 participants.
-
Hyperuricemia research is mostly interventional.
12 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
12 total, page 1 of 1
A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic Hyperuricemia
Novo Nordisk A/S
NCT06859073
Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients
Arthrosi Therapeutics
NCT07116746
Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-301)
Arthrosi Therapeutics
NCT06846515
Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-302)
Arthrosi Therapeutics
NCT06439602
PK and Safety Evaluation Study of SAP-001 in Adult Subjects With Normal and Impaired Renal Function
Shanton Pharma Pte.
NCT06729853
The Diet Gout Trial
Johns Hopkins University
NCT03569020
Sex-related Differences in Arterial Stiffness in Type 2 Diabetics: Role of Uric Acid
University of Missouri-Columbia
NCT03648996
The Effects of BCRP Q141K on Allopurinol Pharmacokinetics and Dynamics
University of California, San Francisco
NCT02956278
The Effect of Colchicine on the Pharmacokinetic Profile of LC350189 in Healthy Aldults.
LG Chem
NCT03927677
The Effect of Naproxen on the Pharmacokinetic Profile of LC350189 in Healthy Adults
LG Chem
NCT04139824
Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients with Hyperuricemia
Urica Therapeutics
NCT06056570
A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency
BioCryst Pharmaceuticals
NCT01407874
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 3 |
| Phase 3 | 2 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Hyperuricemia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Hyperuricemia trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Hyperuricemia page
12 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Hyperuricemia trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Arthrosi Therapeutics sponsors the most Hyperuricemia trials on record, review their full trial history before evaluating a specific study. See Arthrosi Therapeutics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hyperuricemia condition card totals 12 registered trials; most-linked intervention Placebo; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.